<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="review-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Burns Trauma</journal-id><journal-id journal-id-type="iso-abbrev">Burns Trauma</journal-id><journal-title-group><journal-title>Burns &#x00026; Trauma</journal-title></journal-title-group><issn pub-type="ppub">2321-3868</issn><issn pub-type="epub">2321-3876</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">28546987</article-id><article-id pub-id-type="pmc">5441009</article-id><article-id pub-id-type="publisher-id">80</article-id><article-id pub-id-type="doi">10.1186/s41038-017-0080-1</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Current progress in understanding the molecular pathogenesis of burn scar contracture</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Tan</surname><given-names>Jianglin</given-names></name><address><email>jianglintan@aliyun.com</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Wu</surname><given-names>Jun</given-names></name><address><email>junwu@burnstrauma.com</email></address><xref ref-type="aff" rid="Aff2">2</xref></contrib><aff id="Aff1"><label>1</label>Institute of Burn Research, State Key Laboratory of Trauma, Burns and Combined Injuries, Chongqing Key Laboratory for Disease Proteomics, Southwest Hospital, Third Military Medical University, Chongqing, 400038 China </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.412615.5</institution-id><institution>Department of Burns, </institution><institution>First Affiliated Hospital of Sun Yat-sen University, </institution></institution-wrap>Guangzhou, 510080 China </aff></contrib-group><pub-date pub-type="epub"><day>22</day><month>5</month><year>2017</year></pub-date><pub-date pub-type="pmc-release"><day>22</day><month>5</month><year>2017</year></pub-date><pub-date pub-type="collection"><year>2017</year></pub-date><volume>5</volume><elocation-id>14</elocation-id><history><date date-type="received"><day>13</day><month>1</month><year>2017</year></date><date date-type="accepted"><day>17</day><month>4</month><year>2017</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2017</copyright-statement><license license-type="OpenAccess"><license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><abstract id="Abs1"><p>Abnormal wound healing is likely to induce scar formation, leading to dysfunction, deformity, and psychological trauma in burn patients. Despite the advancement of medical care treatment, scar contracture in burn patients remains a challenge. Myofibroblasts play a key role in scar contracture. It has been demonstrated that myofibroblasts, as well as inflammatory cells, fibroblasts, endothelial cells, and epithelial cells, secrete transforming growth factor-&#x003b2;1 (TGF-&#x003b2;1) and other cytokines, which can promote persistent myofibroblast activation via a positive regulation loop. In addition to the cellular contribution, the microenvironments, including the mechanical tension and integrin family, are also involved in scar contracture. Most recently, eukaryotic initiation factor 6 (eIF6), an upstream regulator of TGF-&#x003b2;1, has been demonstrated to be involved in myofibroblast differentiation and contraction in both in vitro fibroblast-populated collagen lattice (FPCL) and in vivo external mechanical stretch models. Moreover, the data showed that P311 could induce the transdifferentiation of epidermal stem cells to myofibroblasts by upregulating TGF-&#x003b2;1 expression, which mediated myofibroblast contraction. In this review, we briefly described the most current progress on the biological function of myofibroblasts in scar contracture and subsequently summarized the molecular events that initiated contracture. This would help us better understand the molecular basis of scar contracture as well as to find a comprehensive strategy for preventing/managing scar contracture.</p></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Scar</kwd><kwd>Contracture</kwd><kwd>Burn</kwd><kwd>Molecular pathogenesis</kwd></kwd-group><funding-group><award-group><funding-source><institution>NSFC</institution></funding-source><award-id>81401603</award-id><principal-award-recipient><name><surname>Tan</surname><given-names>Jianglin</given-names></name></principal-award-recipient></award-group></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2017</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Background</title><p>It is commonly accepted that scars are a pathologic wound healing response to burn injuries, traumatic injuries, and surgeries. Hypertrophic scars and keloids, which only occur in humans, present with exuberant scar formation [<xref ref-type="bibr" rid="CR1">1</xref>]. Although these disorders do not pose a health risk, the scar contracture resulting in dysfunction and deformity remains a challenge in the clinic [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR3">3</xref>]. The management of the scar contracture, such as surgical intervention, drugs, silicone materials, pressure therapy, splinting, lasers, and radiation, is used to control scar formation and contracture, but it is still far from achieving our expected outcomes [<xref ref-type="bibr" rid="CR4">4</xref>]. Schneider found that 620 of the 1865 analyzed adult burn patients developed at least one joint contracture, which meant 33% of patients had dysfunction in their joints after burn injuries [<xref ref-type="bibr" rid="CR5">5</xref>].</p><p>Wound healing proceeds through three overlapping stages. The inflammatory stage is triggered by injury, wherein platelets, neutrophils, and macrophages release inflammatory mediators and cytokines that participate in the recruitment of inflammatory cells, fibroblasts, endothelial cells, and epithelial cells. The proliferative stage involves fibroblast activation, myofibroblast differentiation, and extracellular matrix (ECM) deposition. In this phase, the myofibroblasts have acquired contractile properties that can contract the wound and promote re-epithelialization. The third healing stage is matrix remodeling, including scar tissue remodeling. During this stage, the persistent activation of myofibroblasts, imbalance of deposition and degradation of ECM, and poor arrangement of newly formed fibers can lead to scar formation.</p><p>Myofibroblasts, a type of cell differentiated from quiescent fibroblasts and other cells, have been demonstrated to play an essential role in the induction and maintenance of scar contracture. In normal acute wound healing, the myofibroblasts are temporally limited and cleared by apoptosis in the third healing phase when the tissues are repaired. However, in hypertrophic scars and keloids, these myofibroblasts persist at a high number for long periods and promote the synthesis of &#x003b1;-smooth muscle actin (&#x003b1;-SMA), transforming growth factor-&#x003b2;1 (TGF-&#x003b2;1), and other growth factors, and they have sustained contractile ability via the TGF-&#x003b2;1 positive loop [<xref ref-type="bibr" rid="CR6">6</xref>].</p></sec><sec id="Sec2"><title>Review</title><sec id="Sec3"><title>The origins and characteristics of myofibroblasts</title><p>In the inflammatory stage, fibrocytes and fibroblasts are believed to be activated in response to inflammatory factors; they then migrate to the location of injury based on a chemoattractant gradient and differentiate into myofibroblasts. In general, most myofibroblasts are derived from fibroblast differentiation around the local wound area [<xref ref-type="bibr" rid="CR7">7</xref>]. In addition, other myofibroblasts may originate from pericytes [<xref ref-type="bibr" rid="CR8">8</xref>], smooth muscle cells from the vasculature [<xref ref-type="bibr" rid="CR9">9</xref>], fibrocytes from bone marrow-derived peripheral blood [<xref ref-type="bibr" rid="CR10">10</xref>], epithelial cells through the epithelial-mesenchymal transition (EMT) [<xref ref-type="bibr" rid="CR11">11</xref>], epidermal stem cells [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR13">13</xref>], local mesenchymal stem cells, and bone marrow-derived mesenchymal stem cells [<xref ref-type="bibr" rid="CR14">14</xref>].</p><p>The myofibroblast cell is a phenotypically intermediate cell type between fibroblasts and smooth muscle cells. The myofibroblasts exhibit the characteristics of smooth muscle cells, containing high-contractile stress fibers. The stress fibers consist of &#x003b1;-SMA protein, which can be used to differentiate between myofibroblasts and fibroblasts in tissues. However, it remains difficult and complicated to discriminate between myofibroblasts and other contractile cells, such as smooth muscle cells, pericytes, and myoepithelial cells, even if the smooth muscle cells express smooth muscle myosin heavy chain, h-caldesmon (H-CAD), smoothelin, and the muscle intermediate filament protein, desmin, which are absent from myofibroblasts [<xref ref-type="bibr" rid="CR15">15</xref>]. There are a lot of cytokines and mechanical microenvironment factors that contribute to scar contracture (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>).<fig id="Fig1"><label>Fig. 1</label><caption><p>The cytokines and mechanical environment contribute to myofibroblast contraction: The inflammatory factors and growth factors such as TGF-&#x003b2;1, CTGF, IGF, PDGF, VEGF, IL-6, IL-8, Fizz1, and YAP1 could upregulate the expression of TGF-&#x003b2;1, &#x003b1;-SMA, collagen I, collagen III, and fibronectin via a positive feedback loop. The exogenous mechanical force can also promote the expression of &#x003b1;-SMA via FAK, RAC, NADPH oxidase, MAPK/p38, and Rho signaling pathways, enhancing the contractile force. bFGF, EGF, IFN-&#x003b3;, and IL-10 can inhibit the myofibroblasts differentiation, thereby decreasing the contraction. P311 could upregulate the TGF-&#x003b2;1 expression. In contrast, eIF6 inhibits the TGF-&#x003b2;1 expression as an upstream regulator</p></caption><graphic xlink:href="41038_2017_80_Fig1_HTML" id="MO1"/></fig>
</p></sec><sec id="Sec4"><title>The cytokine contribution to scar contracture</title><sec id="Sec5"><title>Transforming growth factor-&#x003b2; family</title><p>It has been demonstrated that TGF-&#x003b2;1 is one of the most important factors controlling myofibroblast differentiation and function. TGF-&#x003b2; is found in all tissues, and it consists of three isoforms, &#x003b2;1, &#x003b2;2, and &#x003b2;3. Binding of active TGF-&#x003b2;1 to the TGF-&#x003b2; receptor type II leads to the phosphorylation and recruitment of TGF-&#x003b2; receptor type I. The heteromeric receptor complex induces the phosphorylation of Smad2/3, followed by association with Smad4. Subsequently, the Smad complex translocates into the nucleus to enhance gene transcription via cooperation with DNA transcription factors. Additionally, it induces overproduction of &#x003b1;-SMA, collagen I, collagen III, fibronectin (FN), and other cytokines [<xref ref-type="bibr" rid="CR16">16</xref>]. TGF-&#x003b2;1 can also reduce matrix metalloproteinases (MMPs) activity via decreasing proteases, such as tissue inhibitor of metalloproteinases (TIMPs) I and II [<xref ref-type="bibr" rid="CR17">17</xref>]. The TGF-&#x003b2;/Smads signaling pathway is a positive autocrine loop in both hypertrophic scar and keloid formation, which then increases the stress fiber stabilization and stiffness of the microenvironment.</p><p>Importantly, TGF-&#x003b2;1 is an inducer of myofibroblast differentiation, which is considered a potential therapeutic target for hypertrophic scars and keloids. It has been reported that peroxisome proliferator-activated receptor-&#x003b3; (PPAR&#x003b3;) ligands, 15d-PGJ2 and GW7845, could inhibit the expression and phosphorylation of TGF-&#x003b2;1/Smads [<xref ref-type="bibr" rid="CR18">18</xref>]. Either disruption or neutralization of TGF-&#x003b2;/Smads signaling by botulinum toxin type A, tetrandrine, baicalein, loureirin B, or the Uighur medicine ASMq can decrease the myofibroblast properties [<xref ref-type="bibr" rid="CR19">19</xref>]. In addition, TGF-&#x003b2;1 could also promote myofibroblast differentiation independent of Smads signaling and instead act via the wnt, p38, and PI3K/PKA2 signaling pathways [<xref ref-type="bibr" rid="CR20">20</xref>]. P311, identified by suppressive subtraction hybridization as potentially involved in smooth muscle (SM) myogenesis, was highly expressed in hypertrophic scars and could induce a TGF-&#x003b2;1-independent, nonfibrogenic myofibroblast phenotype [<xref ref-type="bibr" rid="CR21">21</xref>, <xref ref-type="bibr" rid="CR22">22</xref>]. Furthermore, in the renal fibrosis model, it was found that overexpression of P311 was concurrent with the expression of &#x003b1;-SMA and TGF-&#x003b2;1 via the TGF-&#x003b2;1/Smad signaling pathway [<xref ref-type="bibr" rid="CR23">23</xref>]. Eukaryotic initiation factor 6 (eIF6), acting as a key binding protein of P311 [<xref ref-type="bibr" rid="CR24">24</xref>], has recently been demonstrated by our team as a novel upstream regulator to inhibit myofibroblast differentiation at the TGF-&#x003b2;1 transcription level via H2A.Z occupancy and Sp1 recruitment. Additionally, there is downregulation of &#x003b1;-SMA and collagen I expression [<xref ref-type="bibr" rid="CR25">25</xref>]. In addition, our next study demonstrated that eIF6-mediated TGF-&#x003b2;1 can also be regulated by external mechanical stretch [<xref ref-type="bibr" rid="CR26">26</xref>].</p></sec><sec id="Sec6"><title>Positive growth factors and cytokines</title><p>In addition, many other growth factors show positive roles in myofibroblast differentiation, such as connective tissue growth factor (CTGF), platelet-derived growth factor (PDGF), insulin growth factor (IGF), and vascular endothelial growth factor (VEGF) [<xref ref-type="bibr" rid="CR27">27</xref>, <xref ref-type="bibr" rid="CR28">28</xref>]. CTGF could synergize the action of TGF-&#x003b2;, promoting ECM production and scar contracture. Inhibition of the expression of CTGF can reduce the formation of hypertrophic scars. Likewise, PDGF is released into the wound and induces myofibroblast activation directly or in synergy with TGF-&#x003b2;1. PDGF stimulates fibroblast proliferation and regulates collagen synthesis via extracellular signaling-regulated kinase (ERK) and the PI3K/JNK signaling pathway. Blocking of PDGF receptors &#x003b1; and &#x003b2; was shown to inhibit myofibroblast formation. IGF acts as a mitogenic factor to enhance the expression of collagens I and III while also reducing the release of collagenase. VEGF could induce the expression of collagen I and promote scar formation [<xref ref-type="bibr" rid="CR27">27</xref>].</p><p>Moreover, interleukin-6 (IL-6) and interleukin-8 (IL-8) increase &#x003b1;-SMA transcription in fibroblast cultures [<xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR30">30</xref>]. Similarly, nerve growth factor enhanced &#x003b1;-SMA expression in fibroblasts [<xref ref-type="bibr" rid="CR31">31</xref>]. Fizz1 induced the expression of &#x003b1;-SMA [<xref ref-type="bibr" rid="CR32">32</xref>]. YAP1 contributes to the maintenance of a synthetic and contractile phenotype in fibrosis [<xref ref-type="bibr" rid="CR33">33</xref>]. Agonists of myofibroblast contraction, such as angiotensin-II, endothelin-1, and thrombin, can upregulate the expression of &#x003b1;-SMA [<xref ref-type="bibr" rid="CR34">34</xref>&#x02013;<xref ref-type="bibr" rid="CR36">36</xref>]. As a result, these inflammatory cytokines play roles in myofibroblast differentiation and scar contracture [<xref ref-type="bibr" rid="CR37">37</xref>].</p></sec><sec id="Sec7"><title>Negative growth factors and cytokines</title><p>In contrast, some negative factors act against myofibroblast differentiation. Basic fibroblast growth factor (bFGF, FGF2), epidermal growth factor (EGF), interferon-&#x003b3; (IFN-&#x003b3;), interleukin-10 (IL-10), prostaglandin E2 (PGE2), eIF6, and TGF-&#x003b2;3 have been shown to suppress the expression of &#x003b1;-SMA and ECM synthesis [<xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR38">38</xref>, <xref ref-type="bibr" rid="CR39">39</xref>]. bFGF has been shown to suppress myofibroblast function and &#x003b1;-SMA expression by antagonizing TGF-&#x003b2;1. EGF could negatively regulate the role of TGF-&#x003b2;1 in inducing myofibroblast contraction through attenuating autologous release of TGF-&#x003b2;1. IFN-&#x003b3; and IL-1&#x003b2; induced apoptosis in myofibroblasts and antagonized TGF-&#x003b2;1 regulation and production [<xref ref-type="bibr" rid="CR40">40</xref>, <xref ref-type="bibr" rid="CR41">41</xref>]. Additionally, TGF-&#x003b2;3 exerted suppressive effects on myofibroblasts in a 3-D repair model [<xref ref-type="bibr" rid="CR42">42</xref>].</p></sec></sec><sec id="Sec8"><title>The mechanical microenvironment contribution to scar contracture</title><sec id="Sec9"><title>Mechanical tension</title><p>Hypertrophic scars frequently occur at particular sites, including the anterior chest wall, auricle, scapula, and suprapubic regions, which are frequently subjected to the high stretch tension from the natural daily movements of the body [<xref ref-type="bibr" rid="CR43">43</xref>]. The activity of myofibroblasts depends on the mechanical microenvironment. The stress fibers, fibronectin, and smooth muscle actin appear earlier in the inflammatory stage, which can increase the mechanical tension by association with the ECM. With mechano-sensitive ion channels in the plasma membrane, integrin-mediated stress perception and geometrical changes of myofibroblasts can sense stress [<xref ref-type="bibr" rid="CR44">44</xref>]. Fibrosis tissue exerts greater forces of 20&#x02013;100&#x000a0;kPa with a collagen-dense tendon [<xref ref-type="bibr" rid="CR45">45</xref>]. In contractile wound granulation tissue and myofibroblasts cultured on elastic substrates, the threshold stiffness for the expression of &#x003b1;-SMA in stress fibers is approximately 20&#x000a0;kPa [<xref ref-type="bibr" rid="CR46">46</xref>]. In liver fibrosis, hepatic stellate cells can be activated with 15&#x000a0;kPa of pressure and then differentiate into &#x003b1;-SMA-positive myofibroblasts [<xref ref-type="bibr" rid="CR47">47</xref>].</p><p>&#x003b1;-SMA has been demonstrated as a mechano-sensitive protein that induces a rapid mechanism to control the myofibroblast contractile function. There is positive regulation between stress and &#x003b1;-SMA expression level. The exogenous mechanical force, when applied through integrins, activates the Rho or mitogen-activated protein kinase (MAPK)/p38 signaling pathway, which then enhances the activation of serum response factor (SRF) and increases &#x003b1;-SMA transcription and incorporation into actin filaments. The persistent upregulation of &#x003b1;-SMA increases the intracellular tension and induces a higher force compared to the cytoplasmic actin stress fiber, which stimulates ECM contraction [<xref ref-type="bibr" rid="CR48">48</xref>]. A decrease in the intracellular stress will make the myofibroblasts insensitive to external mechanical factors via interfering with &#x003b1;-SMA, inhibiting the Rho/Rho-associated kinase pathway effect on myosin activity, interfering with mega karyoblastic leukemia factor 1 (MKL1) that is linked with mechanical stress, and interfering with YAP/TAZ transcription factors that mediate mechano-responses [<xref ref-type="bibr" rid="CR49">49</xref>&#x02013;<xref ref-type="bibr" rid="CR52">52</xref>].</p></sec><sec id="Sec10"><title>Integrin family</title><p>Integrin is an essential mechano transducer that is connected with stress fibers in cells and the ECM surrounding the cells [<xref ref-type="bibr" rid="CR53">53</xref>]. These signal mediators are cell surface receptors that consist of two isoforms, &#x003b1; and &#x003b2; subunits. Integrin is involved in the activation of latent TGF-&#x003b2;1 and production of collagen, &#x003b1;-SMA and connective tissue growth factor (CTGF) via reactive FAK, RAC, and NADPH oxidase as well as an oxygen species (ROS)-dependent mechanism [<xref ref-type="bibr" rid="CR54">54</xref>]. Fibroblasts with integrin &#x003b2;<sub>1</sub> knockout are less able to adhere to and contract the ECM [<xref ref-type="bibr" rid="CR55">55</xref>]. Integrins &#x003b1;<sub>1</sub>&#x003b2;<sub>1</sub>, &#x003b1;<sub>2</sub>&#x003b2;<sub>1</sub>, &#x003b1;<sub>3</sub>&#x003b2;<sub>1</sub>, &#x003b1;<sub>v</sub>&#x003b2;<sub>5</sub>, &#x003b1;<sub>5</sub>&#x003b2;<sub>1</sub>, &#x003b1;<sub>v</sub>&#x003b2;<sub>3</sub>, &#x003b1;<sub>v</sub>&#x003b2;<sub>6</sub>, &#x003b1;<sub>v</sub>&#x003b2;<sub>8</sub>, and &#x003b1;<sub>11</sub>&#x003b2;<sub>1</sub> were demonstrated to partially participate in fibroblast proliferation, collagen contraction, and myofibroblast differentiation [<xref ref-type="bibr" rid="CR56">56</xref>]. Deletion of integrin &#x003b1;<sub>3</sub>&#x003b2;<sub>1</sub> decreased the accumulation of myofibroblasts and collagen I, which decreased the fibrosis [<xref ref-type="bibr" rid="CR57">57</xref>]. Moreover, some other integrins, such as integrins &#x003b1;<sub>v</sub>&#x003b2;<sub>5</sub>, &#x003b1;<sub>v</sub>&#x003b2;<sub>3</sub>, and &#x003b1;<sub>8</sub>&#x003b2;<sub>1</sub>, were shown to bind to LAP-TGF-&#x003b2;1 and are involved in TGF-&#x003b2;1 activation [<xref ref-type="bibr" rid="CR58">58</xref>, <xref ref-type="bibr" rid="CR59">59</xref>].</p></sec></sec></sec><sec id="Sec11"><title>Conclusions</title><p>After injury, the quiescent fibroblasts and other original cells are activated in response to inflammatory signals, such as TGF-&#x003b2;1. Following the TGF-&#x003b2;/Smad signaling cascade, TGF-&#x003b2;1 enhances gene transcription, as demonstrated by the upregulation of &#x003b1;-SMA, collagen I/III, and other fibrotic genes. Meanwhile, the expression of TGF-&#x003b2;1 is also increased by a positive feedback loop. Furthermore, eIF6 and P311 were involved in myofibroblast differentiation and contraction via regulating the TGF-&#x003b2;1 expression. This indicated that eIF6 and P311 may be new potential target genes for treating scar contracture. In addition, there are other cytokines, such as growth factors and inflammatory relative factors, which can up/downregulate myofibroblast contracture. Continuing ECM alignment creates larger surfaces for adhesion formation, which connects TGF-&#x003b2;-LAP-LTBP and integrins. The larger adhesions permit the development of stronger stress fibers and generation of a higher contractile force.</p><p>In the wound repair phase, contraction can close the original wound and reduce the surface area. However, the continuation of contraction after wound healing can have high clinical morbidity of the joint contractures, functional loss, delayed return to work, and poor cosmetic results. The molecular basis/pathogenesis of scar contracture is complicated and includes cellular factors and environmental contributions. No single treatment method has been demonstrated to be effective [<xref ref-type="bibr" rid="CR60">60</xref>]. To find the appropriate treatment for scar contractures, we prefer to consider a comprehensive strategy, including cytokines and environmental aspects, and then translate the basic discoveries into potential therapies.</p></sec></body><back><glossary><title>Abbreviations</title><def-list><def-item><term>bFGF</term><def><p>Basic fibroblast growth factor</p></def></def-item><def-item><term>CTGF</term><def><p>Connective tissue growth factor</p></def></def-item><def-item><term>EGF</term><def><p>Epidermal growth factor</p></def></def-item><def-item><term>eIF6</term><def><p>Eukaryotic initiation factor 6</p></def></def-item><def-item><term>EMT</term><def><p>Epithelial-mesenchymal transition</p></def></def-item><def-item><term>ERK</term><def><p>Extracellular signaling-regulated kinase</p></def></def-item><def-item><term>FN</term><def><p>fibronectin</p></def></def-item><def-item><term>FPCL</term><def><p>Fibroblast-populated collagen lattice</p></def></def-item><def-item><term>H-CAD</term><def><p>h-Caldesmon</p></def></def-item><def-item><term>IGF</term><def><p>Insulin growth factor</p></def></def-item><def-item><term>MAPK</term><def><p>Mitogen-activated protein kinase</p></def></def-item><def-item><term>MKL</term><def><p>Megakaryoblastic leukemia factor</p></def></def-item><def-item><term>MMP</term><def><p>Matrix metalloproteinase</p></def></def-item><def-item><term>PDGF</term><def><p>Platelet-derived growth factor</p></def></def-item><def-item><term>PG</term><def><p>Prostaglandin</p></def></def-item><def-item><term>PPAR&#x003b3;</term><def><p>Peroxisome proliferator-activated receptor-&#x003b3;</p></def></def-item><def-item><term>SRF</term><def><p>Serum response factor</p></def></def-item><def-item><term>TGF-&#x003b2;1</term><def><p>Transforming growth factor-&#x003b2;1</p></def></def-item><def-item><term>TIMPs</term><def><p>Tissue inhibitor of metalloproteinases</p></def></def-item><def-item><term>VEGF</term><def><p>Vascular endothelial growth factor</p></def></def-item><def-item><term>&#x003b1;-SMA</term><def><p>&#x003b1;-Smooth muscle actin</p></def></def-item></def-list></glossary><ack><title>Acknowledgements</title><p>None.</p><sec id="FPar1"><title>Funding</title><p>This work was supported by NSFC (81401603).</p></sec><sec id="FPar2"><title>Availability of data and materials</title><p>Not applicable.</p></sec><sec id="FPar3"><title>Authors&#x02019; contributions</title><p>JT was a major contributor in writing the manuscript and revising it critically for important intellectual content. JW supervised the writing of the manuscript and revised it critically for important intellectual content. Both authors read and approved the final manuscript.</p></sec><sec id="FPar4"><title>Competing interests</title><p>The authors declare that they have no competing interests.</p></sec><sec id="FPar5"><title>Consent for publication</title><p>Not applicable.</p></sec><sec id="FPar6"><title>Ethics approval and consent to participate</title><p>Not applicable.</p></sec></ack><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oosterwijk</surname><given-names>AM</given-names></name><name><surname>Mouton</surname><given-names>LJ</given-names></name><name><surname>Schouten</surname><given-names>H</given-names></name><name><surname>Disseldorp</surname><given-names>LM</given-names></name><name><surname>van der Schans</surname><given-names>CP</given-names></name><name><surname>Nieuwenhuis</surname><given-names>MK</given-names></name></person-group><article-title>Prevalence of scar contractures after burn: A systematic review</article-title><source>Burns</source><year>2017</year><volume>43</volume><issue>1</issue><fpage>41</fpage><lpage>49</lpage><pub-id pub-id-type="doi">10.1016/j.burns.2016.08.002</pub-id><pub-id pub-id-type="pmid">27639820</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>P</given-names></name></person-group><article-title>Wound healing&#x02014;aiming for perfect skin regeneration</article-title><source>Science</source><year>1997</year><volume>276</volume><issue>5309</issue><fpage>75</fpage><lpage>81</lpage><pub-id pub-id-type="doi">10.1126/science.276.5309.75</pub-id><pub-id pub-id-type="pmid">9082989</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heng</surname><given-names>MC</given-names></name></person-group><article-title>Wound healing in adult skin: aiming for perfect regeneration</article-title><source>Int J Dermatol</source><year>2011</year><volume>50</volume><issue>9</issue><fpage>1058</fpage><lpage>66</lpage><pub-id pub-id-type="doi">10.1111/j.1365-4632.2011.04940.x</pub-id><pub-id pub-id-type="pmid">22126865</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berman</surname><given-names>B</given-names></name><name><surname>Viera</surname><given-names>MH</given-names></name><name><surname>Amini</surname><given-names>S</given-names></name><name><surname>Huo</surname><given-names>R</given-names></name><name><surname>Jones</surname><given-names>IS</given-names></name></person-group><article-title>Prevention and management of hypertrophic scars and keloids after burns in children</article-title><source>J Craniofac Surg</source><year>2008</year><volume>19</volume><issue>4</issue><fpage>989</fpage><lpage>1006</lpage><pub-id pub-id-type="doi">10.1097/SCS.0b013e318175f3a7</pub-id><pub-id pub-id-type="pmid">18650721</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goverman</surname><given-names>J</given-names></name><name><surname>Mathews</surname><given-names>K</given-names></name><name><surname>Goldstein</surname><given-names>R</given-names></name><name><surname>Holavanahalli</surname><given-names>R</given-names></name><name><surname>Kowalske</surname><given-names>K</given-names></name><name><surname>Esselman</surname><given-names>P</given-names></name><etal/></person-group><article-title>Adult Contractures in Burn Injury: A Burn Model System National Database Study</article-title><source>J Burn Care Res</source><year>2017</year><volume>38</volume><issue>1</issue><fpage>e328</fpage><lpage>e336</lpage><pub-id pub-id-type="doi">10.1097/BCR.0000000000000380</pub-id><pub-id pub-id-type="pmid">27380122</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><mixed-citation publication-type="other">Bochaton-Piallat ML, Gabbiani G, Hinz B. The myofibroblast in wound healing and fibrosis: answered and unanswered questions. F1000Res. 2016;5:1&#x02013;8.</mixed-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gabbiani</surname><given-names>G</given-names></name></person-group><article-title>The myofibroblast in wound healing and fibrocontractive diseases</article-title><source>J Pathol</source><year>2003</year><volume>200</volume><issue>4</issue><fpage>500</fpage><lpage>3</lpage><pub-id pub-id-type="doi">10.1002/path.1427</pub-id><pub-id pub-id-type="pmid">12845617</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gokcinar-Yagci</surname><given-names>B</given-names></name><name><surname>Uckan-Cetinkaya</surname><given-names>D</given-names></name><name><surname>Celebi-Saltik</surname><given-names>B</given-names></name></person-group><article-title>Pericytes: properties, functions and applications in tissue engineering</article-title><source>Stem Cell Rev</source><year>2015</year><volume>11</volume><issue>4</issue><fpage>549</fpage><lpage>59</lpage><pub-id pub-id-type="doi">10.1007/s12015-015-9590-z</pub-id><pub-id pub-id-type="pmid">25865146</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hinz</surname><given-names>B</given-names></name></person-group><article-title>Myofibroblasts</article-title><source>Exp Eye Res</source><year>2016</year><volume>142</volume><fpage>56</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1016/j.exer.2015.07.009</pub-id><pub-id pub-id-type="pmid">26192991</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>YB</given-names></name><name><surname>Qu</surname><given-names>X</given-names></name><name><surname>Caruana</surname><given-names>G</given-names></name><name><surname>Li</surname><given-names>J</given-names></name></person-group><article-title>The origin of renal fibroblasts/myofibroblasts and the signals that trigger fibrosis</article-title><source>Differentiation</source><year>2016</year><volume>92</volume><issue>3</issue><fpage>102</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1016/j.diff.2016.05.008</pub-id><pub-id pub-id-type="pmid">27262400</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>C</given-names></name><name><surname>Grimm</surname><given-names>WA</given-names></name><name><surname>Garner</surname><given-names>WL</given-names></name><name><surname>Qin</surname><given-names>L</given-names></name><name><surname>Travis</surname><given-names>T</given-names></name><name><surname>Tan</surname><given-names>N</given-names></name><etal/></person-group><article-title>Epithelial to mesenchymal transition in human skin wound healing is induced by tumor necrosis factor-alpha through bone morphogenic protein-2</article-title><source>Am J Pathol</source><year>2010</year><volume>176</volume><issue>5</issue><fpage>2247</fpage><lpage>58</lpage><pub-id pub-id-type="doi">10.2353/ajpath.2010.090048</pub-id><pub-id pub-id-type="pmid">20304956</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Yao</surname><given-names>Z</given-names></name><name><surname>He</surname><given-names>W</given-names></name><name><surname>Gao</surname><given-names>H</given-names></name><name><surname>Bai</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>S</given-names></name><etal/></person-group><article-title>P311 induces the transdifferentiation of epidermal stem cells to myofibroblast-like cells by stimulating transforming growth factor beta1 expression</article-title><source>Stem Cell Res Ther</source><year>2016</year><volume>7</volume><issue>1</issue><fpage>175</fpage><pub-id pub-id-type="doi">10.1186/s13287-016-0421-1</pub-id><pub-id pub-id-type="pmid">27906099</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yao</surname><given-names>Z</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>He</surname><given-names>W</given-names></name><name><surname>Yang</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Zhan</surname><given-names>R</given-names></name><etal/></person-group><article-title>P311 accelerates skin wound reepithelialization by promoting epidermal stem cell migration through Rho A and Rac1 activation</article-title><source>Stem Cells Dev</source><year>2017</year><volume>26</volume><issue>6</issue><fpage>451</fpage><lpage>460</lpage><pub-id pub-id-type="doi">10.1089/scd.2016.0249</pub-id><pub-id pub-id-type="pmid">27927130</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Markeson</surname><given-names>D</given-names></name><name><surname>Pleat</surname><given-names>JM</given-names></name><name><surname>Sharpe</surname><given-names>JR</given-names></name><name><surname>Harris</surname><given-names>AL</given-names></name><name><surname>Seifalian</surname><given-names>AM</given-names></name><name><surname>Watt</surname><given-names>SM</given-names></name></person-group><article-title>Scarring, stem cells, scaffolds and skin repair</article-title><source>J Tissue Eng Regen Med</source><year>2015</year><volume>9</volume><issue>6</issue><fpage>649</fpage><lpage>68</lpage><pub-id pub-id-type="doi">10.1002/term.1841</pub-id><pub-id pub-id-type="pmid">24668923</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hinz</surname><given-names>B</given-names></name></person-group><article-title>Formation and function of the myofibroblast during tissue repair</article-title><source>J Invest Dermatol</source><year>2007</year><volume>127</volume><issue>3</issue><fpage>526</fpage><lpage>37</lpage><pub-id pub-id-type="doi">10.1038/sj.jid.5700613</pub-id><pub-id pub-id-type="pmid">17299435</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meng</surname><given-names>XM</given-names></name><name><surname>Nikolic-Paterson</surname><given-names>DJ</given-names></name><name><surname>Lan</surname><given-names>HY</given-names></name></person-group><article-title>TGF-beta: the master regulator of fibrosis</article-title><source>Nat Rev Nephrol</source><year>2016</year><volume>12</volume><issue>6</issue><fpage>325</fpage><lpage>38</lpage><pub-id pub-id-type="doi">10.1038/nrneph.2016.48</pub-id><pub-id pub-id-type="pmid">27108839</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robert</surname><given-names>S</given-names></name><name><surname>Gicquel</surname><given-names>T</given-names></name><name><surname>Bodin</surname><given-names>A</given-names></name><name><surname>Lagente</surname><given-names>V</given-names></name><name><surname>Boichot</surname><given-names>E</given-names></name></person-group><article-title>Characterization of the MMP/TIMP imbalance and collagen production induced by IL-1beta or TNF-alpha release from human hepatic stellate cells</article-title><source>PLoS One</source><year>2016</year><volume>11</volume><issue>4</issue><fpage>e0153118</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0153118</pub-id><pub-id pub-id-type="pmid">27046197</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>GY</given-names></name><name><surname>Cheng</surname><given-names>T</given-names></name><name><surname>Zheng</surname><given-names>MH</given-names></name><name><surname>Yi</surname><given-names>CG</given-names></name><name><surname>Pan</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>ZJ</given-names></name><etal/></person-group><article-title>Activation of peroxisome proliferator-activated receptor-gamma inhibits transforming growth factor-beta1 induction of connective tissue growth factor and extracellular matrix in hypertrophic scar fibroblasts in vitro</article-title><source>Arch Dermatol Res</source><year>2009</year><volume>301</volume><issue>7</issue><fpage>515</fpage><lpage>22</lpage><pub-id pub-id-type="doi">10.1007/s00403-009-0959-1</pub-id><pub-id pub-id-type="pmid">19466435</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>M</given-names></name><name><surname>Yan</surname><given-names>T</given-names></name><name><surname>Ma</surname><given-names>K</given-names></name><name><surname>Lai</surname><given-names>L</given-names></name><name><surname>Liu</surname><given-names>C</given-names></name><name><surname>Liang</surname><given-names>L</given-names></name><etal/></person-group><article-title>Botulinum toxin type A inhibits alpha-smooth muscle actin and myosin II expression in fibroblasts derived from scar contracture</article-title><source>Ann Plast Surg</source><year>2016</year><volume>77</volume><issue>3</issue><fpage>e46</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1097/SAP.0000000000000268</pub-id><pub-id pub-id-type="pmid">25144422</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bowley</surname><given-names>E</given-names></name><name><surname>O&#x02019;Gorman</surname><given-names>DB</given-names></name><name><surname>Gan</surname><given-names>BS</given-names></name></person-group><article-title>Beta-catenin signaling in fibroproliferative disease</article-title><source>J Surg Res</source><year>2007</year><volume>138</volume><issue>1</issue><fpage>141</fpage><lpage>50</lpage><pub-id pub-id-type="doi">10.1016/j.jss.2006.07.026</pub-id><pub-id pub-id-type="pmid">17109886</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pan</surname><given-names>D</given-names></name><name><surname>Zhe</surname><given-names>X</given-names></name><name><surname>Jakkaraju</surname><given-names>S</given-names></name><name><surname>Taylor</surname><given-names>GA</given-names></name><name><surname>Schuger</surname><given-names>L</given-names></name></person-group><article-title>P311 induces a TGF-beta1-independent, nonfibrogenic myofibroblast phenotype</article-title><source>J Clin Invest</source><year>2002</year><volume>110</volume><issue>9</issue><fpage>1349</fpage><lpage>58</lpage><pub-id pub-id-type="doi">10.1172/JCI0215614</pub-id><pub-id pub-id-type="pmid">12417574</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname><given-names>J</given-names></name><name><surname>Peng</surname><given-names>X</given-names></name><name><surname>Luo</surname><given-names>G</given-names></name><name><surname>Ma</surname><given-names>B</given-names></name><name><surname>Cao</surname><given-names>C</given-names></name><name><surname>He</surname><given-names>W</given-names></name><etal/></person-group><article-title>Investigating the role of P311 in the hypertrophic scar</article-title><source>PLoS One</source><year>2010</year><volume>5</volume><issue>4</issue><fpage>e9995</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0009995</pub-id><pub-id pub-id-type="pmid">20404911</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yao</surname><given-names>Z</given-names></name><name><surname>Yang</surname><given-names>S</given-names></name><name><surname>He</surname><given-names>W</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Xu</surname><given-names>R</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><etal/></person-group><article-title>P311 promotes renal fibrosis via TGFbeta1/Smad signaling</article-title><source>Sci Rep</source><year>2015</year><volume>5</volume><fpage>17032</fpage><pub-id pub-id-type="doi">10.1038/srep17032</pub-id><pub-id pub-id-type="pmid">26616407</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peng</surname><given-names>X</given-names></name><name><surname>Yuan</surname><given-names>S</given-names></name><name><surname>Tan</surname><given-names>J</given-names></name><name><surname>Ma</surname><given-names>B</given-names></name><name><surname>Bian</surname><given-names>X</given-names></name><name><surname>Xu</surname><given-names>C</given-names></name><etal/></person-group><article-title>Identification of ITGB4BP as a new interaction protein of P311</article-title><source>Life Sci</source><year>2012</year><volume>90</volume><issue>15&#x02013;16</issue><fpage>585</fpage><lpage>90</lpage><pub-id pub-id-type="doi">10.1016/j.lfs.2012.02.008</pub-id><pub-id pub-id-type="pmid">22365962</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>SS</given-names></name><name><surname>Tan</surname><given-names>JL</given-names></name><name><surname>Liu</surname><given-names>DS</given-names></name><name><surname>Loreni</surname><given-names>F</given-names></name><name><surname>Peng</surname><given-names>X</given-names></name><name><surname>Yang</surname><given-names>QQ</given-names></name><etal/></person-group><article-title>Eukaryotic initiation factor 6 modulates myofibroblast differentiation at transforming growth factor-beta1 transcription level via H2A.Z occupancy and Sp1 recruitment</article-title><source>J Cell Sci</source><year>2015</year><volume>128</volume><issue>21</issue><fpage>3977</fpage><lpage>89</lpage><pub-id pub-id-type="doi">10.1242/jcs.174870</pub-id><pub-id pub-id-type="pmid">26395397</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shu</surname><given-names>Q</given-names></name><name><surname>Tan</surname><given-names>J</given-names></name><name><surname>Ulrike</surname><given-names>VD</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Yang</surname><given-names>S</given-names></name><etal/></person-group><article-title>Involvement of eIF6 in external mechanical stretch-mediated murine dermal fibroblast function via TGF-beta1 pathway</article-title><source>Sci Rep</source><year>2016</year><volume>6</volume><fpage>36075</fpage><pub-id pub-id-type="doi">10.1038/srep36075</pub-id><pub-id pub-id-type="pmid">27824055</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lian</surname><given-names>N</given-names></name><name><surname>Li</surname><given-names>T</given-names></name></person-group><article-title>Growth factor pathways in hypertrophic scars: molecular pathogenesis and therapeutic implications</article-title><source>Biomed Pharmacother</source><year>2016</year><volume>84</volume><fpage>42</fpage><lpage>50</lpage><pub-id pub-id-type="doi">10.1016/j.biopha.2016.09.010</pub-id><pub-id pub-id-type="pmid">27636511</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mattyasovszky</surname><given-names>SG</given-names></name><name><surname>Wollstadter</surname><given-names>J</given-names></name><name><surname>Martin</surname><given-names>A</given-names></name><name><surname>Ritz</surname><given-names>U</given-names></name><name><surname>Baranowski</surname><given-names>A</given-names></name><name><surname>Ossendorf</surname><given-names>C</given-names></name><etal/></person-group><article-title>Inhibition of contractile function in human joint capsule myofibroblasts by targeting the TGF-beta1 and PDGF pathways</article-title><source>PLoS One</source><year>2016</year><volume>11</volume><issue>1</issue><fpage>e0145948</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0145948</pub-id><pub-id pub-id-type="pmid">26730954</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shintani</surname><given-names>Y</given-names></name><name><surname>Fujiwara</surname><given-names>A</given-names></name><name><surname>Kimura</surname><given-names>T</given-names></name><name><surname>Kawamura</surname><given-names>T</given-names></name><name><surname>Funaki</surname><given-names>S</given-names></name><name><surname>Minami</surname><given-names>M</given-names></name><etal/></person-group><article-title>IL-6 secreted from cancer-associated fibroblasts mediates chemoresistance in NSCLC by increasing epithelial-mesenchymal transition signaling</article-title><source>J Thorac Oncol</source><year>2016</year><volume>11</volume><issue>9</issue><fpage>1482</fpage><lpage>92</lpage><pub-id pub-id-type="doi">10.1016/j.jtho.2016.05.025</pub-id><pub-id pub-id-type="pmid">27287412</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clement</surname><given-names>S</given-names></name><name><surname>Pascarella</surname><given-names>S</given-names></name><name><surname>Conzelmann</surname><given-names>S</given-names></name><name><surname>Gonelle-Gispert</surname><given-names>C</given-names></name><name><surname>Guilloux</surname><given-names>K</given-names></name><name><surname>Negro</surname><given-names>F</given-names></name></person-group><article-title>The hepatitis C virus core protein indirectly induces alpha-smooth muscle actin expression in hepatic stellate cells via interleukin-8</article-title><source>J Hepatol</source><year>2010</year><volume>52</volume><issue>5</issue><fpage>635</fpage><lpage>43</lpage><pub-id pub-id-type="doi">10.1016/j.jhep.2009.10.035</pub-id><pub-id pub-id-type="pmid">20347177</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yorifuji</surname><given-names>M</given-names></name><name><surname>Sawaji</surname><given-names>Y</given-names></name><name><surname>Endo</surname><given-names>K</given-names></name><name><surname>Kosaka</surname><given-names>T</given-names></name><name><surname>Yamamoto</surname><given-names>K</given-names></name></person-group><article-title>Limited efficacy of COX-2 inhibitors on nerve growth factor and metalloproteinases expressions in human synovial fibroblasts</article-title><source>J Orthop Sci</source><year>2016</year><volume>21</volume><issue>3</issue><fpage>381</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1016/j.jos.2016.01.004</pub-id><pub-id pub-id-type="pmid">26876621</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martins</surname><given-names>V</given-names></name><name><surname>De Los Santos</surname><given-names>FG</given-names></name><name><surname>Wu</surname><given-names>Z</given-names></name><name><surname>Capelozzi</surname><given-names>V</given-names></name><name><surname>Phan</surname><given-names>SH</given-names></name><name><surname>Liu</surname><given-names>T</given-names></name></person-group><article-title>FIZZ1-induced myofibroblast transdifferentiation from adipocytes and its potential role in dermal fibrosis and lipoatrophy</article-title><source>Am J Pathol</source><year>2015</year><volume>185</volume><issue>10</issue><fpage>2768</fpage><lpage>76</lpage><pub-id pub-id-type="doi">10.1016/j.ajpath.2015.06.005</pub-id><pub-id pub-id-type="pmid">26261086</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Piersma</surname><given-names>B</given-names></name><name><surname>de Rond</surname><given-names>S</given-names></name><name><surname>Werker</surname><given-names>PM</given-names></name><name><surname>Boo</surname><given-names>S</given-names></name><name><surname>Hinz</surname><given-names>B</given-names></name><name><surname>van Beuge</surname><given-names>MM</given-names></name><etal/></person-group><article-title>YAP1 is a driver of myofibroblast differentiation in normal and diseased fibroblasts</article-title><source>Am J Pathol</source><year>2015</year><volume>185</volume><issue>12</issue><fpage>3326</fpage><lpage>37</lpage><pub-id pub-id-type="doi">10.1016/j.ajpath.2015.08.011</pub-id><pub-id pub-id-type="pmid">26458763</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><mixed-citation publication-type="other">Yang X, Wang Y, Yan S, Sun L, Yang G, Li Y, et al. Effect of testosterone on the proliferation and collagen synthesis of cardiac fibroblasts induced by angiotensin II in neonatal rat. Bioengineered. 201;8(1):14&#x02013;20.</mixed-citation></ref><ref id="CR35"><label>35.</label><mixed-citation publication-type="other">Kiya K, Kubo T, Kawai K, Matsuzaki S, Muramatsu R, Maeda D, et al. Endothelial cell-derived endothelin-1 is involved in abnormal scar formation by dermal fibroblasts through RhoA/Rho-kinase pathway. Exp Dermatol. 2016. doi:10.1111/exd.13264.</mixed-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>WH</given-names></name><name><surname>Deng</surname><given-names>YT</given-names></name><name><surname>Hsieh</surname><given-names>YP</given-names></name><name><surname>Wu</surname><given-names>KJ</given-names></name><name><surname>Kuo</surname><given-names>MY</given-names></name></person-group><article-title>Thrombin activates latent TGFbeta1 via integrin alphavbeta1 in gingival fibroblasts</article-title><source>J Dent Res</source><year>2016</year><volume>95</volume><issue>8</issue><fpage>939</fpage><lpage>45</lpage><pub-id pub-id-type="doi">10.1177/0022034516634288</pub-id><pub-id pub-id-type="pmid">26912222</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bianchi</surname><given-names>E</given-names></name><name><surname>Taurone</surname><given-names>S</given-names></name><name><surname>Bardella</surname><given-names>L</given-names></name><name><surname>Signore</surname><given-names>A</given-names></name><name><surname>Pompili</surname><given-names>E</given-names></name><name><surname>Sessa</surname><given-names>V</given-names></name><etal/></person-group><article-title>Involvement of pro-inflammatory cytokines and growth factors in the pathogenesis of Dupuytren&#x02019;s contracture: a novel target for a possible future therapeutic strategy?</article-title><source>Clin Sci (Lond)</source><year>2015</year><volume>129</volume><issue>8</issue><fpage>711</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1042/CS20150088</pub-id><pub-id pub-id-type="pmid">26201022</pub-id></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>JS</given-names></name><name><surname>Kim</surname><given-names>JY</given-names></name><name><surname>Cho</surname><given-names>JY</given-names></name><name><surname>Kang</surname><given-names>JS</given-names></name><name><surname>Yu</surname><given-names>YH</given-names></name></person-group><article-title>Epidermal growth factor (EGF) antagonizes transforming growth factor (TGF)-beta1-induced collagen lattice contraction by human skin fibroblasts</article-title><source>Biol Pharm Bull</source><year>2000</year><volume>23</volume><issue>12</issue><fpage>1517</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1248/bpb.23.1517</pub-id><pub-id pub-id-type="pmid">11145189</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Guan</surname><given-names>H</given-names></name><name><surname>Cai</surname><given-names>W</given-names></name><name><surname>Bai</surname><given-names>X</given-names></name><name><surname>Fang</surname><given-names>X</given-names></name><etal/></person-group><article-title>Anti-fibrotic actions of interleukin-10 against hypertrophic scarring by activation of PI3K/AKT and STAT3 signaling pathways in scar-forming fibroblasts</article-title><source>PLoS One</source><year>2014</year><volume>9</volume><issue>5</issue><fpage>e98228</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0098228</pub-id><pub-id pub-id-type="pmid">24878845</pub-id></element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poosti</surname><given-names>F</given-names></name><name><surname>Bansal</surname><given-names>R</given-names></name><name><surname>Yazdani</surname><given-names>S</given-names></name><name><surname>Prakash</surname><given-names>J</given-names></name><name><surname>Beljaars</surname><given-names>L</given-names></name><name><surname>van den Born</surname><given-names>J</given-names></name><etal/></person-group><article-title>Interferon gamma peptidomimetic targeted to interstitial myofibroblasts attenuates renal fibrosis after unilateral ureteral obstruction in mice</article-title><source>Oncotarget</source><year>2016</year><volume>7</volume><issue>34</issue><fpage>54240</fpage><lpage>54252</lpage><pub-id pub-id-type="pmid">27509062</pub-id></element-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bronnum</surname><given-names>H</given-names></name><name><surname>Eskildsen</surname><given-names>T</given-names></name><name><surname>Andersen</surname><given-names>DC</given-names></name><name><surname>Schneider</surname><given-names>M</given-names></name><name><surname>Sheikh</surname><given-names>SP</given-names></name></person-group><article-title>IL-1beta suppresses TGF-beta-mediated myofibroblast differentiation in cardiac fibroblasts</article-title><source>Growth Factors</source><year>2013</year><volume>31</volume><issue>3</issue><fpage>81</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.3109/08977194.2013.787994</pub-id><pub-id pub-id-type="pmid">23734837</pub-id></element-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>Z</given-names></name><name><surname>Kishimoto</surname><given-names>Y</given-names></name><name><surname>Hasan</surname><given-names>A</given-names></name><name><surname>Welham</surname><given-names>NV</given-names></name></person-group><article-title>TGF-beta3 modulates the inflammatory environment and reduces scar formation following vocal fold mucosal injury in rats</article-title><source>Dis Model Mech</source><year>2014</year><volume>7</volume><issue>1</issue><fpage>83</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.1242/dmm.013326</pub-id><pub-id pub-id-type="pmid">24092879</pub-id></element-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ogawa</surname><given-names>R</given-names></name><name><surname>Mitsuhashi</surname><given-names>K</given-names></name><name><surname>Hyakusoku</surname><given-names>H</given-names></name><name><surname>Miyashita</surname><given-names>T</given-names></name></person-group><article-title>Postoperative electron-beam irradiation therapy for keloids and hypertrophic scars: retrospective study of 147 cases followed for more than 18&#x000a0;months</article-title><source>Plast Reconstr Surg</source><year>2003</year><volume>111</volume><issue>2</issue><fpage>547</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.1097/01.PRS.0000040466.55214.35</pub-id><pub-id pub-id-type="pmid">12560675</pub-id></element-citation></ref><ref id="CR44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van De Water</surname><given-names>L</given-names></name><name><surname>Varney</surname><given-names>S</given-names></name><name><surname>Tomasek</surname><given-names>JJ</given-names></name></person-group><article-title>Mechanoregulation of the myofibroblast in wound contraction, scarring, and fibrosis: opportunities for new therapeutic intervention</article-title><source>Adv Wound Care (New Rochelle)</source><year>2013</year><volume>2</volume><issue>4</issue><fpage>122</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.1089/wound.2012.0393</pub-id><pub-id pub-id-type="pmid">24527336</pub-id></element-citation></ref><ref id="CR45"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hinz</surname><given-names>B</given-names></name></person-group><article-title>Tissue stiffness, latent TGF-beta1 activation, and mechanical signal transduction: implications for the pathogenesis and treatment of fibrosis</article-title><source>Curr Rheumatol Rep</source><year>2009</year><volume>11</volume><issue>2</issue><fpage>120</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1007/s11926-009-0017-1</pub-id><pub-id pub-id-type="pmid">19296884</pub-id></element-citation></ref><ref id="CR46"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goffin</surname><given-names>JM</given-names></name><name><surname>Pittet</surname><given-names>P</given-names></name><name><surname>Csucs</surname><given-names>G</given-names></name><name><surname>Lussi</surname><given-names>JW</given-names></name><name><surname>Meister</surname><given-names>JJ</given-names></name><name><surname>Hinz</surname><given-names>B</given-names></name></person-group><article-title>Focal adhesion size controls tension-dependent recruitment of alpha-smooth muscle actin to stress fibers</article-title><source>J Cell Biol</source><year>2006</year><volume>172</volume><issue>2</issue><fpage>259</fpage><lpage>68</lpage><pub-id pub-id-type="doi">10.1083/jcb.200506179</pub-id><pub-id pub-id-type="pmid">16401722</pub-id></element-citation></ref><ref id="CR47"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wells</surname><given-names>RG</given-names></name></person-group><article-title>The role of matrix stiffness in hepatic stellate cell activation and liver fibrosis</article-title><source>J Clin Gastroenterol</source><year>2005</year><volume>39</volume><issue>4 Suppl 2</issue><fpage>S158</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1097/01.mcg.0000155516.02468.0f</pub-id><pub-id pub-id-type="pmid">15758652</pub-id></element-citation></ref><ref id="CR48"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Zohar</surname><given-names>R</given-names></name><name><surname>McCulloch</surname><given-names>CA</given-names></name></person-group><article-title>Multiple roles of alpha-smooth muscle actin in mechanotransduction</article-title><source>Exp Cell Res</source><year>2006</year><volume>312</volume><issue>3</issue><fpage>205</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1016/j.yexcr.2005.11.004</pub-id><pub-id pub-id-type="pmid">16325810</pub-id></element-citation></ref><ref id="CR49"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gates</surname><given-names>DH</given-names></name><name><surname>Lee</surname><given-names>JS</given-names></name><name><surname>Hultman</surname><given-names>CS</given-names></name><name><surname>Cairns</surname><given-names>BA</given-names></name></person-group><article-title>Inhibition of rho-kinase impairs fibroblast stress fiber formation, confluence, and contractility in vitro</article-title><source>J Burn Care Res</source><year>2007</year><volume>28</volume><issue>3</issue><fpage>507</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1097/BCR.0B013E318053DAD8</pub-id><pub-id pub-id-type="pmid">17438482</pub-id></element-citation></ref><ref id="CR50"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sandbo</surname><given-names>N</given-names></name><name><surname>Lau</surname><given-names>A</given-names></name><name><surname>Kach</surname><given-names>J</given-names></name><name><surname>Ngam</surname><given-names>C</given-names></name><name><surname>Yau</surname><given-names>D</given-names></name><name><surname>Dulin</surname><given-names>NO</given-names></name></person-group><article-title>Delayed stress fiber formation mediates pulmonary myofibroblast differentiation in response to TGF-beta</article-title><source>Am J Physiol Lung Cell Mol Physiol</source><year>2011</year><volume>301</volume><issue>5</issue><fpage>L656</fpage><lpage>66</lpage><pub-id pub-id-type="doi">10.1152/ajplung.00166.2011</pub-id><pub-id pub-id-type="pmid">21856814</pub-id></element-citation></ref><ref id="CR51"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abe</surname><given-names>M</given-names></name><name><surname>Sogabe</surname><given-names>Y</given-names></name><name><surname>Syuto</surname><given-names>T</given-names></name><name><surname>Yokoyama</surname><given-names>Y</given-names></name><name><surname>Ishikawa</surname><given-names>O</given-names></name></person-group><article-title>Evidence that PI3K, Rac, Rho, and Rho kinase are involved in basic fibroblast growth factor-stimulated fibroblast-collagen matrix contraction</article-title><source>J Cell Biochem</source><year>2007</year><volume>102</volume><issue>5</issue><fpage>1290</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1002/jcb.21359</pub-id><pub-id pub-id-type="pmid">17497700</pub-id></element-citation></ref><ref id="CR52"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dai</surname><given-names>X</given-names></name><name><surname>She</surname><given-names>P</given-names></name><name><surname>Chi</surname><given-names>F</given-names></name><name><surname>Feng</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Jin</surname><given-names>D</given-names></name><etal/></person-group><article-title>Phosphorylation of angiomotin by Lats1/2 kinases inhibits F-actin binding, cell migration, and angiogenesis</article-title><source>J Biol Chem</source><year>2013</year><volume>288</volume><issue>47</issue><fpage>34041</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.1074/jbc.M113.518019</pub-id><pub-id pub-id-type="pmid">24106267</pub-id></element-citation></ref><ref id="CR53"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DiPersio</surname><given-names>CM</given-names></name><name><surname>Zheng</surname><given-names>R</given-names></name><name><surname>Kenney</surname><given-names>J</given-names></name><name><surname>Van De Water</surname><given-names>L</given-names></name></person-group><article-title>Integrin-mediated regulation of epidermal wound functions</article-title><source>Cell Tissue Res</source><year>2016</year><volume>365</volume><issue>3</issue><fpage>467</fpage><lpage>82</lpage><pub-id pub-id-type="doi">10.1007/s00441-016-2446-2</pub-id><pub-id pub-id-type="pmid">27351421</pub-id></element-citation></ref><ref id="CR54"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>R</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Xue</surname><given-names>Z</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Fu</surname><given-names>M</given-names></name><name><surname>Lu</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Focal adhesion kinase (FAK) siRNA inhibits human hypertrophic scar by suppressing integrin alpha, TGF-beta and alpha-SMA</article-title><source>Cell Biol Int</source><year>2014</year><volume>38</volume><issue>7</issue><fpage>803</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1002/cbin.10265</pub-id><pub-id pub-id-type="pmid">24523242</pub-id></element-citation></ref><ref id="CR55"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leask</surname><given-names>A</given-names></name></person-group><article-title>Integrin beta1: a mechanosignaling sensor essential for connective tissue deposition by fibroblasts</article-title><source>Adv Wound Care (New Rochelle)</source><year>2013</year><volume>2</volume><issue>4</issue><fpage>160</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1089/wound.2012.0365</pub-id><pub-id pub-id-type="pmid">24527339</pub-id></element-citation></ref><ref id="CR56"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>N</given-names></name><name><surname>Tao</surname><given-names>K</given-names></name><name><surname>Fang</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Effects of integrin alphanubeta3 on differentiation and collagen synthesis induced by connective tissue growth factor in human hypertrophic scar fibroblasts</article-title><source>Int J Mol Med</source><year>2014</year><volume>34</volume><issue>5</issue><fpage>1323</fpage><lpage>34</lpage><pub-id pub-id-type="pmid">25174803</pub-id></element-citation></ref><ref id="CR57"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>KK</given-names></name><name><surname>Wei</surname><given-names>Y</given-names></name><name><surname>Szekeres</surname><given-names>C</given-names></name><name><surname>Kugler</surname><given-names>MC</given-names></name><name><surname>Wolters</surname><given-names>PJ</given-names></name><name><surname>Hill</surname><given-names>ML</given-names></name><etal/></person-group><article-title>Epithelial cell alpha3beta1 integrin links beta-catenin and Smad signaling to promote myofibroblast formation and pulmonary fibrosis</article-title><source>J Clin Invest</source><year>2009</year><volume>119</volume><issue>1</issue><fpage>213</fpage><lpage>24</lpage><pub-id pub-id-type="pmid">19104148</pub-id></element-citation></ref><ref id="CR58"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sarrazy</surname><given-names>V</given-names></name><name><surname>Koehler</surname><given-names>A</given-names></name><name><surname>Chow</surname><given-names>ML</given-names></name><name><surname>Zimina</surname><given-names>E</given-names></name><name><surname>Li</surname><given-names>CX</given-names></name><name><surname>Kato</surname><given-names>H</given-names></name><etal/></person-group><article-title>Integrins alphavbeta5 and alphavbeta3 promote latent TGF-beta1 activation by human cardiac fibroblast contraction</article-title><source>Cardiovasc Res</source><year>2014</year><volume>102</volume><issue>3</issue><fpage>407</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.1093/cvr/cvu053</pub-id><pub-id pub-id-type="pmid">24639195</pub-id></element-citation></ref><ref id="CR59"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bouzeghrane</surname><given-names>F</given-names></name><name><surname>Mercure</surname><given-names>C</given-names></name><name><surname>Reudelhuber</surname><given-names>TL</given-names></name><name><surname>Thibault</surname><given-names>G</given-names></name></person-group><article-title>Alpha8beta1 integrin is upregulated in myofibroblasts of fibrotic and scarring myocardium</article-title><source>J Mol Cell Cardiol</source><year>2004</year><volume>36</volume><issue>3</issue><fpage>343</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.1016/j.yjmcc.2003.11.007</pub-id><pub-id pub-id-type="pmid">15010273</pub-id></element-citation></ref><ref id="CR60"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Junker</surname><given-names>JP</given-names></name><name><surname>Philip</surname><given-names>J</given-names></name><name><surname>Kiwanuka</surname><given-names>E</given-names></name><name><surname>Hackl</surname><given-names>F</given-names></name><name><surname>Caterson</surname><given-names>EJ</given-names></name><name><surname>Eriksson</surname><given-names>E</given-names></name></person-group><article-title>Assessing quality of healing in skin: review of available methods and devices</article-title><source>Wound Repair Regen</source><year>2014</year><volume>22</volume><issue>Suppl 1</issue><fpage>2</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1111/wrr.12162</pub-id><pub-id pub-id-type="pmid">24813357</pub-id></element-citation></ref></ref-list></back></article>